Alexion Pharmaceuticals Other Current Assets

Alexion Pharmaceuticals (ALXN) currently reports a other current assets of $710M as of March 2021. That compares with $580M in the prior-year period — up 22.8% year over year. Use the charts on this page to explore Alexion Pharmaceuticals's other current assets history and peer comparisons.

Alexion Pharmaceuticals's other current assets increased from $580M to $710M — a 22.8% year-over-year increase (period ending March 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alexion Pharmaceuticals reported $710M in other current assets as of March 2021. That compares with $580M in the prior-year period — up 22.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $710M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alexion Pharmaceuticals, and consider following ALXN for alerts when major investors trade the stock.

Alexion Pharmaceuticals is classified in the Healthcare sector. On other current assets, it currently shows $710M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALXN with unrelated industries.